Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan 1;1(1):19-31.

Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update

Affiliations

Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update

Dongfeng Tan et al. Int J Clin Exp Pathol. .

Abstract

Diagnosis and classification of lung and pleural neoplasms are complex due to diverse histopathology and tumor heterogeneity. A large number of immunohistochemical markers have recently become available to facilitate accurate diagnosis and classification of pulmonary and pleural neoplasms. The purpose of this article is to review the current data available on these markers and to provide a practical approach to evaluate pulmonary and pleural neoplasms immunohistochemically. Current literature of immunohistochemical markers related to pulmonary and pleural neoplasms was collected and reviewed. Literature emphasizing differential diagnosis was selected. Data useful in the diagnosis and classification of pulmonary and pleural neoplasms was collated. This review provides an updated overview and general guideline for the practicing surgical pathologists to resolve some of the common differential diagnostic situations in their daily immunohistochemical assessment of pulmonary and pleural neoplasms.

Keywords: Immunohistochemistry; adenocarcinoma; lung; mesothelioma; neuroendocrine neoplasm; non-small cell carcinoma; pleura; small cell carcinoma; spindle cell neoplasm.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hammar SP. Metastatic adenocarcinoma of unknown primary origin. Hum Pathol. 1998;29:1393–1402. - PubMed
    1. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol. 2000;24:1217–1223. - PubMed
    1. Peng WX, Sano T, Oyama T, Kawashima O, Nakajima T. Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma. Lung Cancer. 2005;47:225–233. - PubMed
    1. Sturm N, Rossi G, Lantuejoul S, Laverriere MH, Papotti M, Brichon PY, Brambilla C, Brambilla E. 34BetaE12 expression along the whole spectrum of neuroendocrine pro-liferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma. Histopathology. 2003;42:156–166. - PubMed
    1. Moran CA, Wick MR, Suster S. The role of immunohistochemistry in the diagnosis of malignant mesothelioma. Semin Diagn Pathol. 2000;17:178–183. - PubMed

LinkOut - more resources